General Information of Drug (ID: DM6WWA6)

Drug Name
JTT-252
Indication
Disease Entry ICD 11 Status REF
Type-2 diabetes 5A11 Phase 1 [1]
Cross-matching ID
TTD ID
D0L4GX

References

1 ClinicalTrials.gov (NCT02120976) Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252. U.S. National Institutes of Health.